Literature DB >> 1730533

A pig model of Acanthamoeba keratitis: transmission via contaminated contact lenses.

Y G He1, J P McCulley, H Alizadeh, M Pidherney, J Mellon, J E Ubelaker, G L Stewart, R E Silvany, J Y Niederkorn.   

Abstract

A model of contact lens-induced Acanthamoeba keratitis was developed in Yucatan micropigs. Pigs fitted with parasite-laden soft contact lenses developed corneal infections that clinically and histopathologically mimicked the human counterpart. Three distinct stages of disease became apparent and were categorized as: acute, condensed infiltrate, and resolution stages. Viable parasites were isolated from corneal scrapings and smears were taken during the acute and condensed infiltrate stages. In addition, cysts could be identified deep within the stroma of histological specimens taken during the resolution stages. The characteristic dense, white ring-like infiltrates, stroma edema, keratic precipitates, and the chronic nature of the infections were similar to those observed in human Acanthamoeba keratitis. Histopathological examination of infected corneas revealed extensive neutrophilic infiltrates, stromal necrosis, and disorganization of the collagen lamellae. The strong correlation between the clinical and histopathologic features of contact lens-induced Acanthamoeba keratitis in the pig as well as the anatomical similarity of the pig eye with the human eye make the porcine model a valuable tool for investigations of the immunology, cell biology, and therapy for Acanthamoeba keratitis.

Entities:  

Mesh:

Year:  1992        PMID: 1730533

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  14 in total

Review 1.  The immunobiology of Acanthamoeba keratitis.

Authors:  J Y Niederkorn; H Alizadeh; H F Leher; J P McCulley
Journal:  Springer Semin Immunopathol       Date:  1999

2.  Development of ciprofloxacin-loaded contact lenses using fluorous chemistry.

Authors:  Guoting Qin; Zhiling Zhu; Siheng Li; Alison M McDermott; Chengzhi Cai
Journal:  Biomaterials       Date:  2017-01-31       Impact factor: 12.479

3.  Pathogenesis of acanthamoebic keratitis: hypothesis based on a histological analysis of 30 cases.

Authors:  A Garner
Journal:  Br J Ophthalmol       Date:  1993-06       Impact factor: 4.638

4.  Exacerbation of Acanthamoeba keratitis in animals treated with anti-macrophage inflammatory protein 2 or antineutrophil antibodies.

Authors:  M Hurt; S Apte; H Leher; K Howard; J Niederkorn; H Alizadeh
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

5.  Role of phospholipase A₂ (PLA₂) inhibitors in attenuating apoptosis of the corneal epithelial cells and mitigation of Acanthamoeba keratitis.

Authors:  Trivendra Tripathi; Mahshid Abdi; Hassan Alizadeh
Journal:  Exp Eye Res       Date:  2013-06-20       Impact factor: 3.467

6.  IL-17A-mediated protection against Acanthamoeba keratitis.

Authors:  Amol Suryawanshi; Zhiyi Cao; James F Sampson; Noorjahan Panjwani
Journal:  J Immunol       Date:  2014-12-10       Impact factor: 5.422

7.  Mannose induces the release of cytopathic factors from Acanthamoeba castellanii.

Authors:  H Leher; R Silvany; H Alizadeh; J Huang; J Y Niederkorn
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

Review 8.  Acanthamoeba spp. as agents of disease in humans.

Authors:  Francine Marciano-Cabral; Guy Cabral
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

9.  Induction of morphological and electrophysiological changes in hamster cornea after in vitro interaction with trophozoites of Acanthamoeba spp.

Authors:  Maritza Omaña-Molina; Fernando Navarro-García; Arturo González-Robles; José de Jesús Serrano-Luna; Rafael Campos-Rodríguez; Adolfo Martínez-Palomo; Víctor Tsutsumi; Mineko Shibayama
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

Review 10.  The biology of Acanthamoeba keratitis.

Authors:  Jerry Y Niederkorn
Journal:  Exp Eye Res       Date:  2020-11-19       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.